Image

Global Keratoconjunctivitis Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Keratoconjunctivitis Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Keratoconjunctivitis Market, By Drug Class (NSAIDS, Corticosteroids, Antibiotics, Antivirals, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Keratoconjunctivitis Market

Keratoconjunctivitis Market Analysis and Size

The global keratoconjunctivitis market is expected to witness significant growth during the forecast period. Keratoconjunctivitis is an often under diagnosed and undertreated health problem due to few patients having keratoconjunctivitis with allergic symptoms seek medical attention. Risk factors include age, gender, and family and personal history. About 95% people with this condition having history of atopic dermatitis, with 87% suffering from asthma earlier in life. Young people are at the highest risk of developing this condition. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the global keratoconjunctivitis market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Keratoconjunctivitis is a severe type of eye infection that is characterised by the inflammation of the both cornea and conjunctiva of the eyes. It is usually caused by different allergies, viruses, or bacteria and some are also associated with autoimmune disorders or minor injury. In keratoconjunctivitis, patient mostly experience redness of the eye, blurred vision and eye pain.

Keratoconjunctivitis Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drug Class (NSAIDS, Corticosteroids, Antibiotics, Antivirals, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Bausch Health Companies Inc. (U.S.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Amorphex Therapeutics Holdings, Inc (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Lupin (India), Cipla Inc (India)

Market Opportunities

  • Rapid Urbanization and Pollution Levels
  • Increasing Demand for Retail Pharmacies

Global Keratoconjunctivitis Market Dynamics

Drivers

  • Increase in Keratoconjunctivitis Cases

Keratoconjunctivitis is a rare conjunctivitis condition that occurs around 1 in 10,000 persons. The chances of keratoconjunctivitis infections varies with country and season. It most commonly occurs in warmer climates. This infection is more common in men compared to women. It is somewhat related to atopic dermatitis, which affects about 3% of the population worldwide wherein about 15 to 67% of people have certain types of eye infections. This boost the market growth.

  • Rising Demand for Oral Drugs

Oral drugs is expected to increase the market growth. The segment is projected to accelerate the global market as many products are available in capsule form and tablet form and it is a very feasible route of administration.

Opportunities

  • Rapid Urbanization and Pollution Levels

Rapid urbanization and augmented particulate pollution have increased the occurrence of keratoconjunctivitis in several countries, such as India and China. However, factors such as a dearth of awareness among the general population regarding eye disorders and lack of health insurance control the market in France, Germany, Italy, and Spain.

  • Increasing Demand for Retail Pharmacies

Opportunities for market growth are created by the rise in the number of keratoconjunctivitis treatments provided by retail pharmacies and the rise in the number of retail pharmacies in developed nations. Patients also favour retail pharmacies because they are convenient for acquiring medications.

 Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate eye lubricants could curb the growth of the global keratoconjunctivitis market over a forecast period.

  • Risk of Side-Effects

The associated side effects that comes with the application of drugs of keratoconjunctivitis hampers the market growth. Serious side-effects such as eye pain, change in vision, continued eye redness/irritation and severe side effects such as allergy hampers the market's growth.  

This global keratoconjunctivitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global keratoconjunctivitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Keratoconjunctivitis Market         

The COVID-19 pandemic greatly impacted the pharmaceutical industry's entire supply chain, mostly due to strict lockdown in several regions. Also, the demand for conjunctivitis drugs is increasing in this COVID-19 pandemic, due to increasing number of conjunctivitis cases, in which conjunctivitis was the only symptom in COVID-19 positive patients. Thus, this will leave a significant impact on the global keratoconjunctivitis market.

Global Keratoconjunctivitis Market Scope

The global keratoconjunctivitis market is segmented on the basis of drug class, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

Route of Administration

  • Oral
  • Topical
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Keratoconjunctivitis Market Regional Analysis/Insights

The global keratoconjunctivitis market is analysed and market size insights and trends are provided by drug class, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global keratoconjunctivitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global keratoconjunctivitis market throughout the forecasted period due to the increase government initiatives and developing healthcare facilities.

North America dominates the market due to more cases of keratoconjunctivitis, increased awareness about the keratoconjunctivitis treatment options, and advanced healthcare facilities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Keratoconjunctivitis Market Share Analysis

The global keratoconjunctivitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related global keratoconjunctivitis market

Key players operating in the global keratoconjunctivitis market include:

  • Bausch Health Companies Inc. (U.S.)
  • Merck & Co. Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Amorphex Therapeutics Holdings, Inc (U.S.)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)
  • Dr. Reddy's Laboratories Ltd (India)
  • Endo International plc (Ireland)
  • Lupin (India)
  • Cipla Inc (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Factors such as increase in keratoconjunctivitis cases and rising demand for oral drugs are acting as the major drivers for the global keratoconjunctivitis market.
Bausch Health Companies Inc. (U.S.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Amorphex Therapeutics Holdings, Inc (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Lupin (India), Cipla Inc (India).
Drug Class (NSAIDS, Corticosteroids, Antibiotics, Antivirals, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) are covered in this report.
The major countries covered in the Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials